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ABSTRACT
DNA polymerase h (Pol h) is a low-fidelity DNA poly-
merase that belongs to the family A polymerases
and has been proposed to play a role in somatic
hypermutation. Pol h has the ability to conduct
translesion DNA synthesis opposite an AP site or
thymine glycol, and it was recently proposed to be
involved in base excision repair (BER) of DNA
damage. Here, we show that Pol h has intrinsic
5’-deoxyribose phosphate (5’-dRP) lyase activity
that is involved in single-nucleotide base excision
DNA repair (SN-BER). Full-length human Pol h is a
~300-kDa polypeptide, but we show here that the
98-kDa C-terminal region of Pol h possesses both
DNA polymerase activity and dRP lyase activity
and is sufficient to carry out base excision repair
in vitro. The 5’-dRP lyase activity is independent of
the polymerase activity, in that a polymerase inac-
tive mutant retained full 5’-dRP lyase activity.
Domain mapping of the 98-kDa enzyme by limited
proteolysis and NaBH4 cross-linking with a BER
intermediate revealed that the dRP lyase active
site resides in a 24-kDa domain of Pol h. These
results are consistent with a role of Pol h in BER.
INTRODUCTION
DNA sequences homologous to the mus308 gene of
Drosophila melanogaster were identiﬁed in human
genome database, and the corresponding cDNA was
cloned and mapped to chromosome 3q13.31. As the par-
tial human cDNA encoded a 1762-amino-acid DNA poly-
merase with a molecular mass of 198kDa, this new
polymerase was designated DNA polymerase y (Pol y),
and the corresponding vertebrate locus was named
POLQ (1). Subsequently, a full-length cDNA for POLQ
was cloned and shown to encode a 2592-amino-acid
polypeptide with an amino-terminal helicase domain, a
carboxy-terminal polymerase domain and an intervening
spacer region (2). The mammalian POLQ and Drosophila
mus308 gene products have similar domain arrangements.
In addition to these orthologs, vertebrates have paralogs
of the POLQ gene, HEL308 and POLN. The HEL308
gene product has homology to the helicase domain
of POLQ but does not have a polymerase domain,
whereas the POLN gene product has homology to the
polymerase domain of POLQ, but does not contain a heli-
case domain (3,4).
DNA polymerase y belongs to the family A polymerases
(2,5) typiﬁed by Escherichia coli Pol I (6). Biochemical
studies showed that puriﬁed full-length human Pol y
exhibited template-directed DNA polymerase activity on
nicked double-stranded DNA and on a single-primed
DNA template. Consistent with family A DNA poly-
merases, this activity was resistant to aphidicolin and
inhibited by dideoxynucleotides. In addition, Pol y exhib-
ited a single-stranded DNA-dependent ATPase activity
(2). Fidelity measurements of human Pol y revealed that
the polymerase generates single base pair substitutions at a
rate 10- to 100-fold higher than other characterized family
A DNA polymerases, making it one of the least faithful
member of the family A DNA polymerases (7).
Pol y is capable of conducting translesion DNA synthe-
sis by inserting bases opposite an AP site or thymine
glycol residue in the template strand. It also can extend
an unpaired primer base opposite these lesions (8). Thus,
Pol y is suﬃcient for both the insertion and extension steps
required for bypass of an abasic site. In contrast, Pol y
cannot insert bases opposite a cyclobutane pyrimidine
dimer or a (6–4) photoproduct, but is able to extend prim-
ers after DNA polymerase i had inserted a base opposite
these UV-induced photoproducts (9). A role for Pol y in
somatic hypermutation (SHM) of immunoglobulin genes
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DNA glycosylase (UDG) during SHM generates an apuri-
nic/apyrimidinic (AP) site that is repaired by either trans-
lesion bypass or a base excision repair (BER) process
involving several DNA polymerases and accessory pro-
teins (10–14). Recently, Takeda and associates (15) sug-
gested that Pol y and Pol b are involved in BER of DNA
damage in DT40 cells. They reported that POLQ
–/– cells
exhibited no signiﬁcant increase in sensitivity to methyl
methanesulfonate (MMS) or HmdUrd, but deletion of
the genes for both POLQ and Pol b resulted in
cells more sensitive to these base-damaging agents.
Furthermore, subcellular localization studies demon-
strated that Pol y is rapidly recruited to sites of base
damage that are induced by laser-delivered irradiation
(15). These data along with extract-based in vitro repair
assays suggested that Pol y participates in BER in mam-
malian cells under certain conditions.
To understand the potential involvement of Pol y in
BER in mammalian cells, we cloned, overexpressed and
puriﬁed to near homogeneity the C-terminal 98-kDa
region of Pol y, corresponding to the core polymerase
domain. We also prepared a polymerase-deﬁcient variant
of the enzyme by site-directed mutagenesis, and assessed
activities associated with BER. Our results reveal that the
Pol y polymerase domain possesses both 50-deoxyribose
phosphate (dRP) lyase and DNA polymerase activities
that function together during single-nucleotide BER
in vitro. The 50-dRP lyase activity was also fully active in
the polymerase-deﬁcient mutant. Our observation that Pol
y exhibits DNA polymerase and 50-dRP lyase activities
in vitro lends credence to the argument that Pol y may
have a role in BER in vivo.
MATERIALS AND METHODS
Materials
Synthetic oligodeoxyribonucleotides were from Oligos
Etc, Inc. (Wilsonville, OR, USA) and The Midland
Certiﬁed Reagent Co. (Midland, TX, USA).
[a-
32P]dCTP and [a-
32P]ddATP (3000Ci/mmol), and
[g-
32P]ATP (7000Ci/mmol) were from GE HealthCare
(Piscataway, NJ, USA) and Biomedicals (Irvine, CA,
USA), respectively. Optikinase and terminal deoxynucleo-
tidyl transferase were from USB Corp. (Cleveland,
OH, USA) and Fermentas Inc. (Hanover, MD, USA),
respectively. Protease inhibitor complete (EDTA-free)
was from Roche Molecular Diagnostics (Pleasanton,
CA, USA). Leupeptin, aprotinin and phenylmethylsulfo-
nyl ﬂuoride were from Calbiochem (La Jolla, CA, USA).
Recombinant human Pol b was overexpressed and puri-
ﬁed as described previously (16). Human AP endonuclease
(APE), uracil-DNA glycosylase (UDG) with 84 amino
acids deleted from the amino terminus and DNA ligase I
were puriﬁed as described previously (17–19).
Overproduction and purification of thePol hpolymerase
domain
Based on the cDNA sequence of human Pol y (1,2),
a 2.7-kb cDNA clone was ampliﬁed for overexpression
and production of a 98-kDa C-terminal fragment of
human Pol y using a 50-BamH1 primer: 50-TGC CAA
TCA TGA TGG ATC CTC ATC CCT CTT ACC-30
and a 30-Sal1 primer: 50-CTC TGT TCT TTG CAG
TCG ACT GCA TCT GCA C-30. The ampliﬁed DNA
was digested with BamH1 and Sal1 restriction enzymes,
and the correct DNA fragment was gel-puriﬁed and
ligated into BamH1–Sal1 digested pQE80L (Qiagen).
The resulting plasmid pQE80L-y2.7 was transformed
into E. coli BL21-CodonPlus-RP cells (Stratagene) for
protein production.
Pol y was puriﬁed from 1 to 2l of E. coli
BL21-CodonPlus-RP cells transformed with pQE80L-
y2.7 following induction with 1.0mM IPTG at a temper-
ature of 308C for 3.5h. After harvesting by centrifugation
and storage at –808C, cells were resuspended in buﬀer
(35ml) containing 50mM Tris–HCl, pH 7.5, 150mM
NaCl, 0.5mM 2-mercaptoethanol, 5% glycerol and a
cocktail of proteinase inhibitors. Cells were disrupted in
a French Press chilled to 48C with a constant pressure of
25000psi. The lysate was clariﬁed by centrifugation at
12000g for 20min, and the supernatant was saved for
further puriﬁcation. Imidazole was added to the cleared
lysate to a ﬁnal concentration of 20mM before being
applied to a 2-ml Ni–NTA column (Qiagen). The resin
was washed with 50 column volumes of buﬀer containing
500mM NaCl, 1% Triton X-100, 50mM Tris–HCl, pH
7.5 and 20mM imidazole, followed by several column
volumes of a second wash buﬀer containing 500mM
NaCl, 0.005% NP-40, 50mM Tris–HCl, pH 7.5 and
20mM imidazole. Bound proteins were step-eluted with
the second wash buﬀer also containing 0.25M imidazole.
The buﬀer was exchanged on a Fast Desalt HR 10/10
column (GE Healthcare) equilibrated in 25mM potassium
phosphate, pH 7.5, 10% (v/v) glycerol, 1mM EDTA,
1mM 2-mercaptoethanol, 0.005% (v/v) NP-40 and
75mM KCl. The desalted protein fraction was applied
to a 1.0ml HR 5/5 Mono S column equilibrated in
25mM potassium phosphate, pH 7.5, 10% (v/v) glycerol,
1mM EDTA, 1mM 2-mercaptoethanol and 75mM
KCl. Protein was eluted with a linear KCl gradient
(0.075–0.5M) in this buﬀer, and fractions containing Pol
y were ﬂash frozen in liquid nitrogen in small aliquots.
Generationof polymerase variant
The DNA polymerase activity of Pol y was inactivated by
disrupting the ability of two essential carboxylate side
chains to bind Mg
2+ within motif C of the polymerase
active site. Polymerase domain residues Asp829 and
Glu830, corresponding to residues 2540 and 2541 in full-
length Pol y, were changed to Asn and Gln, respectively,
using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene) and the following oligonucleotides: forward
Pol
 :5 0-CAT CCT TCA ACT CCA TAA TCA ACT
CCT ATA TGA AGT G-30 and reverse Pol
 :5 0-CAC
TTC ATA TAG GAG TTG ATT ATG GAG TTG
AAG GAT G-30. The resulting plasmid bearing the poly-
merase activity mutations was sequenced in its entirety
to conﬁrm the D829N and E830Q substitutions. E. coli
BL21-CodonPlus-RP cells were transformed with this
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ﬁcation of the protein as described above.
DNA polymerase assay
Pol y activity was measured with a gel-based oligonucleo-
tide extension assay as described previously (20–23). An
18-mer primer (50-TGA CCA TGT AAC AGA GAG-30)
was gel puriﬁed, labeled at the 50 end with [g-
32P]ATP and
annealed in a 1:1.4 ratio to a 36-mer template (30-ACT
GGT ACA TTG TCT CTC GCA CTC ACT CTC TTC
TCT-50) in 10mM Tris–HCl, pH 7.5 by heating to 908C
for 5min followed by slow cooling to room temperature.
One picomole primer/template (
32P-end labeled primer)
was incubated with 5nM Pol y in a reaction mix-
ture (10ml) containing 25mM HEPES, pH 7.5, 2mM
2-mercaptoethanol, 0.1mM EDTA, 5mM MgCl2,
50mg/ml acetylated bovine serum albumin and 100mM
each dNTP, as indicated. Following incubation at 378C
for 10min, reactions were stopped on ice by addition of
10ml formamide gel-loading dye. Reaction products were
separated by electrophoresis in a 15% polyacrylamide gel
containing 8M urea in 89mM Tris–HCl, 89mM boric
acid, and 2mM EDTA, pH 8.8. Imaging and data analysis
were performed with a Typhoon PhosphorImager and the
ImageQuant software (GE HealthCare).
Substratepreparation and dRPlyase activity assay
Preparation of the dRP lyase substrate and the dRP lyase
assay conditions were essentially as described previously
(24). Brieﬂy, the reaction mixture (20ml) contained 50mM
HEPES, pH 7.5, 20mM KCl, 2mM DTT, 1mM EDTA
and 50nM preincised
32P-labeled AP site containing
DNA. The reaction was initiated by adding the indicated
amounts of Pol y, mutant Pol y or Pol b, followed by
incubation at 378C. Aliquots (9ml each) were transferred
at the indicated time intervals into the tubes that con-
tained 1ml of freshly prepared 200nM NaBH4. Reaction
mixtures were shifted to 0–18C (on ice) and incubation
was continued for 30min. After heating to 758C for
2min, the reaction products were separated by electro-
phoresis in a 15% polyacrylamide gel containing 8M
urea as described above. Imaging and data analysis were
performed by PhosphorImager and ImageQuant software.
5’-End labeling and substrate preparationfor dRPlyase and
NaBH4cross-linking reactions
Dephosphorylated 17-mer oligodeoxyribonucleotide
(50-UGTS-SGGATCCCCGGGTACBiotin-30) containing
a uracil residue at the 50-end, a disulﬁde bond (S–S) 3nt
from the 50-end, and biotin at the 30-end was phosphory-
lated with Optikinase and [g-
32P]ATP. A 34-mer (50-GTAC
CCGGGGATCCGTACGGCGCATCAGCTGCAG-30)
template was then annealed with 15-mer (50-CTGCAGCT
GATGCGC-30) and 17-mer
32P-labeled oligonucleotides
by heating the solution at 908C for 3min and allowing
the solution to slowly cool to 258C. The
32P-labeled
duplex DNA was treated with human UDG to generate
the
32P-labeled deoxyribose sugar phosphate containing
single nucleotide gapped substrate. The S–S bond was
included in the substrate molecule to enable future studies
on cross-linking within the dRP lyase active site.
Covalent cross-linking of DNA to Polh
A NaBH4 trapping technique was utilized to covalently
cross-link Pol y to DNA (25). The reaction mixture
(10ml) contained 50mM HEPES, pH 7.4, 20mM KCl,
1mM EDTA, 200nM
32P-labeled UDG-treated duplex
DNA, 150nM wild-type Pol y, mutant Pol y or 20nM
Pol b and 1mM NaBH4. Reactions were incubated ﬁrst
on ice for 60min and then for 10min at room tempera-
ture. After these incubations, 10ml SDS–PAGE gel-
loading dye was added to each reaction, boiled for 5min
and protein–DNA cross-linked complexes were separated
by electrophoresis in a 10% NuPAGE Bis–Tris gel with a
MOPS running buﬀer system. Radioactive bands were
visualized with a Typhoon PhosphorImager.
Kinetic measurements of dRPlyase activity of Pol h
Kinetic analysis of the dRP lyase activity of Pol y was
performed with a
32P-labeled 34-bp substrate that had
been pretreated with UDG to generate a
32P-labeled
dRP ﬂap within a single-nucleotide gap in the duplex
DNA. The reaction mixture contained 50mM HEPES,
pH 7.4, 20mM KCl, 1mM EDTA and 100nM
32P-labeled
UDG-treated duplex DNA. For the time course experi-
ment, the reaction mixture (50ml) was assembled at 0–18C
in the above buﬀer. Reactions were initiated by adding
400nM Pol y or the dilution buﬀer (control), as indicated
in ﬁgure legends, and incubated at 378C. Aliquots
(9ml each) were withdrawn at diﬀerent time intervals
and transferred to 0–18C to stop the reaction. DNA pro-
ducts were stabilized by addition of 20mM NaBH4 and
incubated for 30min on ice. Then, an equal volume of gel-
loading buﬀer was added, and the reaction mixture was
incubated at 758C for 2min. The reaction products were
separated by electrophoresis in a 15% polyacrylamide
TBE-Urea gel (Invitrogen, Pre-cast gel) for 30min at con-
stant voltage (200V). To quantify the reaction products,
gels were scanned on a PhosphorImager and the data were
analyzed as above. Reaction rates were determined by
plotting the amount of substrate released as a function
of time, and data were ﬁtted to the appropriate equation
by nonlinear least squares methods. To examine the
inﬂuence of protein concentrations on dRP removal, the
reactions were assembled on ice, as above, and initiated by
adding appropriate dilutions of Pol y, as indicated in
the ﬁgure legends. Reaction mixtures were incubated at
378C for 10min and processed as above.
In vitro SN-BER
Repair assay was performed in a ﬁnal reaction volume
of 30ml. A 35-bp oligonucleotide duplex DNA (250nM)
containing uracil at position 15 was incubated in a BER
reaction mixture that contained 50mM HEPES, pH 7.5,
0.5mM EDTA, 2mM DTT, 20mM KCl, 4mM ATP,
5mM phosphocreatine, 100mg/ml phosphocreatine
kinase, 0.5mM NAD, 15nM UDG, 15nM APE,
200nM DNA ligase I and 400nM or 800nM puriﬁed
Pol y, as indicated. Repair reactions were initiated
1870 Nucleic Acids Research, 2009, Vol. 37,No. 6by the addition of 10mM MgCl2 and 2.2mM[ a-
32P]dCTP
(speciﬁc activity, 1 10
6dpm/pmol), followed by incuba-
tion at 378C. Aliquots (9ml) were withdrawn at the indi-
cated time intervals. Reactions were terminated by the
addition of an equal volume (9ml) of DNA gel-loading
buﬀer. After incubation at 758C for 2min, the reaction
products were separated by electrophoresis in a 15% poly-
acrylamide gel containing 8M urea, and the data were
analyzed as above.
Limited proteolysis and amino-terminal sequencing ofPol h
The puriﬁed human Pol y 98-kDa polymerase domain
(66mg) was subjected to limited proteolysis by mixing
with trypsin (0.66mg) at a 1:100 weight ratio (trypsin:Pol
y) in 100mM Tris–HCl, pH 8.0 and then incubating the
solution at 258C. The ﬁnal reaction mixture volume was
90ml. Aliquots (20ml each) were withdrawn at 5-, 15-, 30-
and 60-min time intervals. A portion of each sample
(18ml) was mixed immediately with 10ml SDS–PAGE
gel-loading buﬀer, boiled for 5min and separated by elec-
trophoresis in a 12% NuPAGE Bis–Tris gel with a
MOPS running buﬀer system. Proteins were electro-
phoretically transferred onto an Immun-Blot PVDF
membrane (7 8.4cm) (Bio-Rad) using a transfer buﬀer
that contained 10mM CAPS [3-(cyclohexylamino)-
1-propanesulfonic acid] and 10% methanol, pH 11.0 at
50V (7V/cm) for 1h. The membrane was stained brieﬂy
with 0.2% (w/v) Coomassie blue R-250 in 45% methanol
and 10% acetic acid and destained with 90% methanol
and 10% acetic acid. The membrane was air-dried, and
protein bands were cut with a scalpel. Amino-terminal
sequencing was performed using a Model 492 Procise
sequencing system (Applied Biosystems) at Wake Forest
University, Winston-Salem, NC. The remaining portion of
the trypsin digested sample (2ml) was subjected to NaBH4
cross-linking to a 50-end labeled dRP lyase DNA
substrate, as described above. The resulting gel was sub-
jected to phosphorimaging, and then the same gel was
silver-stained for protein detection.
RESULTS
Production of Polhpolymerase domain
To facilitate the high-yield production of recombinant
human Pol y in E. coli, we expressed several nested
POLy cDNA clones and screened them to ﬁnd the largest
fragment that retained DNA polymerase activity. From
the full-length human Pol y cDNA (1,2, Copeland, unpub-
lished data), we ampliﬁed 2.7-, 2.1-, 1.8- and 1.3-kbp
cDNA fragments containing the DNA polymerase
domain. Expression of the 2.7-kbp cDNA fragment, cor-
responding to the 98-kDa polymerase domain at the
C-terminus of Pol y (amino acids 1712–2590), produced
soluble protein with the highest yield (data not shown). A
(His)6 aﬃnity tag was added to the N-terminus by trans-
ferring this fragment to the pQE80L expression plasmid,
and protein was overproduced in the E. coli host
BL21-CodonPlus-RP cells. As described in ‘Materials
and Methods’ section, recombinant protein was puriﬁed
to apparent homogeneity by sequential passage over a Ni–
NTA aﬃnity column, a buﬀer exchange column, and a
Mono S cation exchange column (Figure 1A, lane 2). As
a control for analysis of the polymerase activity, a mutant
variant of the Pol y polymerase domain was constructed
that abolished DNA polymerase activity. This was
achieved by altering critical carboxylate residues that
bind active site Mg
2+ ions. Similar alterations in other
DNA polymerases are known to abolish DNA polymerase
catalytic activity without dramatically aﬀecting the overall
structure of the protein (26). Asp829 and Glu830 (corre-
sponding to residues 2540 and 2541 in the full-length Pol
Figure 1. Puriﬁcation of the 98-kDa Pol y from E. coli.( A) The 98-kDa polymerase domain of Pol y was puriﬁed as described in Materials and
Methods section, resolved by SDS–PAGE, and visualized by staining with Coomassie blue. Lane 1, molecular weight markers; lanes 2 and 3, 0.4mg
of the wild-type and mutant Pol y polymerase domains after Mono S chromatography, respectively. (B) Schematic representation of the primer/
terminus sequence. (C and D) DNA polymerase activity of wild-type and mutant Pol y was assayed on a synthetic oligonucleotide primer/template as
described in the Materials and Methods section. (C) Polymerase activity of the wild-type 98-kDa Pol y. Lane 1 is the 50-
32P-end-labeled primer alone;
lane 2, primer and enzyme with no added nucleotides; lane 3, addition of 100mM dCTP; lane 4, addition of 100mM dCTP and 100mM dGTP; lane 5,
addition of all four dNTPs at 100mM each. (D) Polymerase activity of the mutant 98-kDa Pol y. Experimental conditions are the same as in lanes
2–5 in (C).
Nucleic Acids Research,2009, Vol.37, No. 6 1871y) in motif C were changed to Asn and Gln, respectively.
This mutant of the Pol y domain harboring D829N and
E830Q substitutions was overexpressed and puriﬁed using
the same protocol as for the wild-type 98-kDa Pol y prep-
aration (Figure 1A, lane 3).
DNA polymerase activity of the puriﬁed wild-type and
mutant Pol y proteins was determined using an oligonu-
cleotide primer/template as substrate (Figure 1B). The
wild-type 98-kDa Pol y readily incorporated a single
nucleotide when only dCTP was included in the reaction
mixture (Figure 1C, lane 3) and could incorporate 2nt
when the next correct nucleotide also was added
(lane 4), but the enzyme was unable to extend the
primer further when all four nucleotides were present
(lane 5). Thus, the 98-kDa Pol y C-terminal domain exhib-
ited altered activity compared to the full-length 298-kDa
Pol y, which easily extends DNA primers to the end of an
oligonucleotide template (2,9 and Copeland, unpublished
data). Control incubations utilizing the 98-kDa Pol y
double mutant failed to display any DNA polymerase
activity (Figure 1D), indicating complete inactivation of
Pol y polymerase function, as well as the absence of any
signiﬁcant contaminating nuclease or polymerase activities
that may have been carried over from the E. coli host. A
comparison of the single-nucleodide primer-extension
DNA polymerase activity of full-length Pol y and the
98-kDa Pol y is shown in Table 1. The polymerase activ-
ities were similar and also were similar to the activity
reported by Seki et al. (8) for the full-length enzyme.
5’-dRP lyase activity of Pol h
To examine a potential role of human Pol y in BER and to
further characterize its biochemical properties, we assessed
the ability of the puriﬁed wild-type 98-kDa Pol y and its
polymerase-deﬁcient mutant (D829N/E830Q) to process
a BER intermediate substrate. Pol b was included in the
experiments as a reference. A 34-bp oligonucleotide
duplex that contained a uracil residue at position 16
(Figure 2A) was used to measure the release of the
50-dRP group by dRP lyase activity. The uracil-containing
DNA strand was 30-end-labeled with [
32P]ddAMP and
annealed to its complementary strand; the duplex DNA
then was pretreated with UDG and APE. The prepared
DNA substrate, contained a 1-nt gap with a 50-dRP group
and
32P-label at the 30-end of the dRP-containing strand
(Figure 2A). The removal of the dRP group from the
32P-labeled substrate strand is visualized in a denaturing
gel as a band migrating approximately one-half nucleotide
faster than the substrate. The preincised substrate was
incubated with wild-type Pol y (98-kDa peptide), mutant
Pol y or Pol b. The results demonstrated that both
wild-type Pol y and the mutant Pol y could release the
dRP group from the substrate (Figure 2B), and the activ-
ities appeared to be similar. The apparent rates of dRP
removal of Pol y and Pol b were 0.016/min and 0.64/min,
respectively. Under the same reaction conditions, the rate
of dRP lyase activity of Pol y appeared to be about 40-fold
lower than that of Pol b (Figure 2B).
Kinetics andmechanism of dRPlyase
To determine kinetic parameters of 50-dRP group removal
by Pol y, we prepared a 34-bp duplex DNA that contained
uracil at position 16 and a nick between positions 15 and
16, by annealing both a 15-mer and a 50-end
32P-labeled
uracil-containing 17-mer to the 34-mer complementary
DNA strand. The resulting
32P-labeled nicked DNA was
pretreated with UDG to generate the 50-dRP-containing
single-nucleotide gapped substrate; the DNA substrate,
thus prepared, contained a
32P-labeled dRP ﬂap in a
single-nucleotide gap (Figure 3A, 16-mer+
32P-dRP).
The rate of dRP removal by Pol y was determined under
single turnover conditions (i.e. enzyme/DNA=4). The
Figure 2. dRP lyase activity of wild-type and mutant Pol y.
(A) A schematic representation of the dRP lyase substrate (18-mer+
32P-dRP) generated by pretreatment of
32P-labeled 34-bp DNA with
UDG and APE and the expected products
32P-labeled 18-mer product
formed as a result of Pol y (sample) or Pol b (positive control) cata-
lyzed excision of 50-terminal dRP. (B) Preincised DNA substrate
(50nM) was incubated either with no enzyme (lane 1), 40nM wild-
type Pol y (lane 2), 40nM mutant Pol y (lane 3), or 5nM Pol b
(lane 4). Aliquots were withdrawn at the indicated time intervals, and
the DNA products were stabilized and analyzed as described under
Materials and Methods section. A photograph of the phosphorimage,
illustrating the reaction products, is shown. Reaction products were
quantiﬁed using ImageQuant software, and the fraction of the substrate
converted into product was indicated as a percentage under each lane.
The apparent rates for the dRP lyase activity of Pol y and Pol b were
0.016 and 0.64/min, respectively. The positions of substrate and the
product are indicated.
Table 1. Steady-state kinetic parameters for polymerase activities of
full-length and 98-kDa fragment of Pol y
Enzyme Km kcat kcat/Km References
mM min
–1 mM
–1min
–1
Full-length 290-kDa Pol y 7.0 0.67 0.096 (8)
Full-length 290-kDa Pol y 9.0 0.42 0.047 This study
98-kDa fragment Pol y 9.7 0.7 0.072 This study
These measurements were made by a single nucleotide-primer extension
assay.
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dependent manner as monitored by disappearance of the
substrate (Figure 3B), with an observed rate of dRP
removal of  0.14/min (Figure 3C). In other experiments
where substrate was in excess, removal of the 50-dRP
group from the substrate was dependent on the enzyme
concentration (Figure 4A and B).
To conﬁrm that the 50-dRP lyase activity of Pol y was
intrinsic to the 98-kDa peptide, we utilized the NaBH4
cross-linking technique (25). This cross-linking technique
relies on the ability of the C10-aldehyde group of the
50-deoxyribose in the substrate to react with a lysine
g-amine of a protein to form a b-elimination intermediate
(Schiﬀ base) protein–DNA complex; this Schiﬀ base is
recovered as a covalent bond by NaBH4 trapping. We
had previously shown that DNA polymerases, such as
Pol b, Pol g and Pol i, catalyze dRP removal from the
BER intermediate via b-elimination, and the Schiﬀ base
intermediate between these polymerases and DNA can be
trapped by NaBH4 reduction (27). As demonstrated in
Figure 5, both wild-type Pol y and the polymerase-
deﬁcient mutant Pol y could form covalent protein–
DNA products with the BER intermediate substrate
upon treatment with NaBH4. This indicates that the Pol
y polymerase domain possesses functional 50-dRP lyase
activity.
Domain mappingof the98-kDa peptide of Polh
To probe domain organization of the Pol y 98-kDa poly-
merase domain and to localize the 50-dRP lyase active site
of Pol y, we subjected the puriﬁed protein to controlled
proteolysis with trypsin, and then we identiﬁed the diges-
tion products by amino-terminal sequencing. Samples
from the incubation with trypsin were withdrawn at
diﬀerent time intervals. A portion of each sample was
separated by SDS–PAGE, transferred onto a PVDF mem-
brane and subjected to amino-terminal sequencing as
described under ‘Materials and Methods’ section
(Figure 6). Digestion for 5min completely degraded the
98-kDa enzyme and produced two major fragments with
molecular masses of about 33 and 24kDa; several minor
polypeptides of higher and lower molecular masses also
were produced. With longer incubations of 30 and 60min,
four fragments persisted and were designated as fragments
II, III, IV and V, respectively (Figure 6A). The 24-kDa
Figure 3. Kinetic measurements of dRP lyase activity of Pol y. The loss
of dRP from the nicked AP-site containing DNA substrate was exam-
ined as a function of incubation time, and the rate of dRP removal by
Pol y was determined under single turnover conditions (i.e. enzyme/
DNA=4). The reaction was performed with Pol y as described
under Materials and Methods section. (A) Schematic representation
of the DNA substrate prepared by annealing a 15-mer oligonucleotide,
a 17-mer oligonucleotide containing
32P-labeled uracil at the 50-end,
and a 34-mer oligonucleotide template. (B) The duplex DNA
(100nM) was pretreated with UDG and then reacted with 400nM
Pol y. Aliquots were withdrawn at the indicated time intervals and
stabilized by the addition of 20mM NaBH4 and incubation on ice
for 30min. Then, an equal volume of gel-loading dye buﬀer was
added, and the reaction products were separated by precast 15%
TBE-Urea gels. A representative phosphorimage of the polyacrylamide
gel illustrates product analysis at various times (lanes 1–5) with and
without Pol y.( C) Time course data were analyzed using ImageQuant
software and ﬁtted to an exponential equation by using nonlinear least
squares methods to determine the reaction rate (kobs=0.14/min).
Figure 4. Inﬂuence of protein concentrations on dRP release by Pol y.
The dRP lyase reactions were performed with diﬀerent concentrations
of Pol y as described under Materials and Methods section. Reaction
conditions and product analysis were as described in Figure 3.
(A) UDG pretreated DNA substrate was mixed with the indicated
amounts of Pol y and incubated at 378C. The migration positions of
the substrate and the product (
32P-dRP) are indicated. (B) Amounts of
32P-labeled dRP released from the substrate was quantiﬁed and plotted
against Pol y concentrations. Data were ﬁtted to a straight-line
equation.
Nucleic Acids Research,2009, Vol.37, No. 6 1873fragment appeared to be further digested to a smaller
molecular mass polypeptide resulting in a doublet in
the gel, whereas the 20-kDa polypeptide and some
high-molecular-mass polypeptides almost disappeared
(Figure 6A). Amino-terminal sequence analysis of several
of these protease-resistant fragments (denoted as I–VI in
Figure 6A) revealed that the 33-, 24-, 23-, 14- and 9-kDA
polypeptides (II to VI) begin with Phe
124, Cys
545, Gly
557,
Leu
423 and Asn
41, respectively (Figure 6B). These results
indicated that the 23-kDa (IV) polypeptide resulted from
removal of 12 amino acids from the amino terminus of the
24-kDa (III) polypeptide. Fragment I, with a molecular
mass of 42kDa, failed to exhibit reasonable sequence data
due to low abundance. The domains of the 98-kDa Pol y
were aligned (Figure 6C) based on the molecular masses
of these protease-resistant fragments and their amino-
terminal sequences.
Localization of thedRP lyase active site
To localize the dRP lyase active site within the 98-kDa Pol
y, portions of the tryptic digests of Pol y (see above) were
incubated with the
32P-labeled dRP lyase substrate and
subjected to NaBH4 cross-linking as in Figure 5. This pro-
tocol was used to assess the capacity of the tryptic frag-
ments for cross-linking and if successful to improve the
yield of cross-linked material for sequencing. Reaction
mixtures that were digested with trypsin for 5min or
15min produced major 33-kDa and 24-kDa fragments
(Figure 6A), but only the 24-kDa fragment was radiola-
beled following cross-linking (Figure 6D). Furthermore,
longer incubations of 30min and 60min revealed that
the radiolabeled 23- and 24-kDa peptides persisted and
appeared as a doublet in the gel (Figure 6D), similar to
the doublet observed upon staining with Coomassie blue
or silver (Figure 6A and E, respectively). These observa-
tions suggested that even prolonged incubation with tryp-
sin only partially converted the 24-kDa peptide to the
23-kDa peptide, and that both fragments contain the
Schiﬀ base dRP lyase nucleophile, i.e. dRP lyase active
site. Taken together, these results indicate that the
24-kDa tryptic fragment is a domain of Pol y that contains
the dRP lyase active site and retains the ability to form a
covalent DNA–protein complex with a BER intermediate
(Figure 6D).
In vitro baseexcision repair activity
Since the 98-kDa Pol y was able to cleave the 50-dRP ﬂap
from a BER intermediate and also retained DNA poly-
merase activity, we asked whether the 98-kDa enzyme was
capable of supporting BER in vitro. We assembled repair
reaction mixtures containing a 35-bp DNA substrate with
uracil opposite guanine and puriﬁed human enzymes,
including UDG, AP endonuclease, DNA ligase I and the
98-kDa Pol y. Reactions were initiated by the addition of
Mg
2+ and [a-
32P]dCTP, and repair activity was monitored
by the incorporation of [a-
32P]dCMP in place of dUMP
into a ligated 35-bp DNA product as a function of incu-
bation time and concentration of Pol y (Figure 7). In vitro
repair activity was dependent on both enzyme concentra-
tion and incubation time (Figure 7A and B), conﬁrming
that human Pol y catalyzed suﬃcient dRP removal and
1-nt gap ﬁlling to support single-nucleotide BER.
DISCUSSION
Abasic sites in DNA are common intermediates in several
important DNA transactions within eukaryotic cells,
including SHM, translesion DNA synthesis and BER.
For example, SHM of immunoglobulin variable region
genes is triggered by the action of activation-induced cyti-
dine deaminase (28), which deaminates deoxycytosine to
deoxyuracil. The abasic sites could be processed by AP
endonuclease and Pol b in an error-free pathway, but
such a repair system would not be beneﬁcial for SHM.
Several lines of evidence support the idea that faithful
repair mediated by Pol b is suppressed during SHM.
First, using a mouse model Rajeswky and his associates
(29) demonstrated that Pol b is not required in SHM.
Second, we recently showed that the expression of Pol b
in the SHM-proﬁcient human BL2 cell line was strongly
down regulated (30). Third, Maizels and associates (31,32)
reported that during immunoglobulin gene diversiﬁcation
in B cells, AP sites were preferentially processed by the
MRE11-RAD50-NSB1 nuclease complex rather than by
AP endonuclease.
Figure 5. NaBH4 cross-linking of wild-type and mutant Pol y. The
reaction conditions and product analysis were as described under
Materials and Methods section. UDG pretreated DNA substrate
(200nM) as described in Figure 3A was mixed with dilution buﬀer
(lane 1), 20nM Pol b (lane 2), 150nM wild-type Pol y (lane 3) or
150nM mutant Pol y (lane 4) and 1mM NaBH4. The reaction mixtures
were incubated on ice for 1h followed by incubation at room temper-
ature for 10min. Covalently cross-linked DNA–protein products were
separated by 10% NuPAGE Bis–Tris gel, and the gel was scanned on a
PhosphorImager. The positions of cross-linked products and free DNA
are indicated.
1874 Nucleic Acids Research, 2009, Vol. 37,No. 6Although Pol y is a family A DNA polymerase, it exhib-
its unusual properties that permit eﬃcient bypass of
abasic sites. In fact, Pol y is able to synthesize through
these damaged sites with an eﬃciency that is comparable
to that displayed on a corresponding undamaged template
(8). The unique ability of Pol y to insert and extend mis-
paired nucleotides opposite AP sites suggests an important
role for Pol y in SHM consistent with the observation that
Figure 6. Limited proteolysis of Pol y with trypsin. (A) Puriﬁed 98-kDa Pol y (66mg) was digested at 258C with trypsin (0.66mg) at a weight ratio
(trypsin:Pol y) of 1:100 in 100mM Tris–HCl, pH 8.0. Aliquots were withdrawn at 5-, 15-, 30- and 60-min time intervals, as indicated at the ‘top’ of
the photograph. A portion of each digested sample was mixed with 10ml SDS–PAGE gel-loading buﬀer and resolved on a 12% NuPAGE Bis–Tris
gel. The proteins were transferred onto a PVDF membrane for amino-terminal sequencing, as described under Materials and Methods section. The
positions of Pol y, tryptic peptides and protein markers are indicated. (B) Amino-terminal sequencing was performed using the Procise sequencing
system, Model 492 (Applied Biosystems). The amino-terminal sequences of peptides I–VI are shown. (C) The domain organization of 98-kDa Pol y is
depicted. (D) Portions of the trypsin digested samples from (A) were reacted with 50-end-labeled dRP lyase DNA substrate and subjected to NaBH4
cross-linking as in Figure 5. The gel was scanned on a PhosphorImager. The positions of cross-linked Pol y, 23- and 24-kDa peptides are indicated.
(E) The gel in (D) was stained with silver to detect protein fragments. The positions of Pol y, 23- and 24-kDA peptides are indicated.
Nucleic Acids Research,2009, Vol.37, No. 6 1875deletion of the Pol y gene in mice decreased mutations in
the Ig H chain by more than 80% (14). While these studies
suggested involvement of Pol y in translesion bypass
during SHM, recent observations with DT40 cells also
support some role for Pol y in BER (15).
In this report we established that Pol y, primarily
known as a lesion bypass DNA polymerase, also possesses
50-dRP lyase and single-nucleotide gap-ﬁlling activities
that are usually associated with BER. The dRP lyase
activity is independent of polymerase activity, since a
polymerase inactive mutant retained full dRP lyase activ-
ity. Using limited proteolysis and sodium borohydride
cross-linking techniques, we demonstrated that the dRP
lyase activity resides in a 24-kDa domain in the 98-kDa
carboxy-terminal region of Pol y. This 24-kDa domain
contains the three conserved motifs (A, B and C) found
in all family A and B polymerases (1). In the 24-kDa
domain Lys2383, near motif B, is conserved in Pol y
from vertebrate species as well as in other family A poly-
merases, and this residue could represent a candidate
nucleophile for the dRP lyase activity. In investigating
roles for the N-terminal 2/3 of the enzyme, it will be of
interest to determine how the full-length enzyme inﬂuences
overall BER eﬃciency in vivo. Similarly, Pol y is highly
expressed in germinal center B cells, where SHM and class
switch recombination occur (33). Identiﬁcation of protein
partners or cofactors that interact with full-length Pol y
may help to assign roles for Pol y in these processes.
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